The plant manufactures raw materials, including chemicals and intermediates used in pharmaceutical manufacturing, InPharma reported.
The new facility will accommodate high-volume processes and back-end integration for starting materials or intermediates that will then be further processed in Asymchem’s Tianjin and Fuxin facilities.
The new facility will free up capacity at other Asymchem’s sites in China, allowing its manufacturing resources to be used in a more efficient manner, the company said.
Asymchem CEO Hao Hong said Dunhua operational will support existing and new manufacturing contracts, and will help the company expand in the global custom development and manufacturing markets.